RYJ:NYE-Invesco Raymond James SB-1 Equity ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 71.858

Change

0.00 (0.00)%

Market Cap

N/A

Volume

678.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+0.05 (+0.04%)

USD 14.94B
VOT Vanguard Mid-Cap Growth Index ..

+0.60 (+0.25%)

USD 14.12B
IJK iShares S&P Mid-Cap 400 Growth..

+0.08 (+0.09%)

USD 9.84B
XMMO Invesco S&P MidCap Momentum ET..

+0.44 (+0.37%)

USD 2.43B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+0.05 (+0.04%)

USD 1.08B
JSMD Janus Henderson Small/Mid Cap ..

+0.20 (+0.27%)

USD 0.38B
ETHO Amplify ETF Trust

+0.09 (+0.16%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

+0.30 (+0.44%)

USD 0.17B
IPO Renaissance IPO ETF

-0.23 (-0.53%)

USD 0.15B
BFOR Barron's 400 ETF

+0.28 (+0.40%)

USD 0.15B

ETFs Containing RYJ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.29% 82% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.29% 70% C- 66% D+
Trailing 12 Months  
Capital Gain 31.31% 83% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.31% 83% B 71% C-
Trailing 5 Years  
Capital Gain 74.54% 67% D+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.54% 67% D+ 73% C
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike